Verve Therapeutics, Inc. (VERV)
NASDAQ: VERV · Real-Time Price · USD
4.740
-0.480 (-9.20%)
Mar 31, 2025, 1:16 PM EDT - Market open
VERV's stock price has decreased by -63.78% in the past year and price targets may not have had time to catch up.
Verve Therapeutics Analyst Ratings
Total Analysts
5
Consensus Rating
Strong Buy
Price Target
$25.50
Upside
+437.97%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +216.46% | Mar 25, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $17 → $15 | Buy | Maintains | $17 → $15 | +216.46% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +216.46% | Feb 28, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $29 → $32 | Strong Buy | Maintains | $29 → $32 | +575.11% | Nov 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $20 → $17 | Buy | Maintains | $20 → $17 | +258.65% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $14 | Strong Buy | Maintains | $15 → $14 | +195.36% | Nov 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $30 → $29 | Strong Buy | Maintains | $30 → $29 | +511.81% | Aug 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +216.46% | Aug 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +321.94% | Aug 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +216.46% | May 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $56 → $40 | Strong Buy | Maintains | $56 → $40 | +743.88% | Apr 3, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $35 | Buy | Reiterates | $35 | +638.40% | Feb 28, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $22 | Hold | Reiterates | $22 | +364.14% | Sep 13, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $22 | Hold | Reiterates | $22 | +364.14% | Aug 29, 2023 |
| Guggenheim | Guggenheim | Strong Buy Maintains $56 → $55 | Strong Buy | Maintains | $56 → $55 | +1,060.34% | Aug 15, 2023 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.